Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases

Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases

Abstract Introduction Carbapenem-resistant organisms (CRO) have emerged as a significant worldwide issue. However, the availability of efficacious antibiotics for treating CRO infections remains limited. Polymyxins, including colistin sulfate, represent the last-line therapeutic option against CRO i...

Full description

Bibliographic Details
Main Authors: Yuanbing Wu, Shanshan Jiang, Dongyang Li, Yaxue Wu, Qian Li, Xing Wang, Bin Liu, Haiyan Bao, Depei Wu, Xiaohui Hu
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-01-01
Series:Infectious Diseases and Therapy
Subjects:
Polymyxins
Colistin
Hematological diseases
Carbapenem-resistant organisms
Infections
Online Access:https://doi.org/10.1007/s40121-023-00909-8

Internet

https://doi.org/10.1007/s40121-023-00909-8

Similar Items